Advertisement
Advertisement
AXGN
Axogen, Inc. Common Stock
45.36
USDSponsored
+1.01
+2.28%
Aug 07, 14:42 UTC -4
Open
AXGN Earnings Reports
Positive Surprise Ratio
AXGN beat 31 of 43 last estimates.
72%
Next Report
Date of Next Report
Oct 27, 2026
Estimate for Q3 26 (Revenue/ EPS)
$74.66M
/$0.12
Implied change from Q2 26 (Revenue/ EPS)
+7.06%
/--
Implied change from Q3 25 (Revenue/ EPS)
+24.26%
/--
Axogen, Inc. Common Stock earnings per share and revenue
On Jul 29, 2026, AXGN reported earnings of 0.12 USD per share (EPS) for Q2 26, missing the estimate of 0.12 USD, resulting in a -3.15% surprise. Revenue reached 69.73 million, compared to an expected 68.44 million, with a 1.89% difference. The market reacted with a +0.53% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 10 analysts forecast an EPS of 0.12 USD, with revenue projected to reach 74.66 million USD, implying an increase of 0.00% EPS, and increase of 7.06% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Teleflex Incorporated
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.29
Actual
$1.76
Surprise
+36.04%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.36
Actual
-$0.36
Surprise
+1.96%
GLOBUS MEDICAL INC
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.12
Actual
$1.34
Surprise
+19.50%
Tandem Diabetes Care, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.31
Surprise
+4.94%
Artivion, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.01
Actual
$0.13
Surprise
+1,174.51%
Delcath Systems Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
$0.07
Surprise
+176.25%
Treace Medical Concepts, Inc. Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.30
Actual
-$0.24
Surprise
+21.05%
Inogen Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.14
Surprise
+10.88%
CVRx, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.53
Actual
-$0.53
Surprise
+0.90%
Hyperfine, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+1.96%
FAQ
What were Axogen, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Axogen, Inc. Common Stock reported EPS of $0.12, missing estimates by -3.15%, and revenue of $69.73M, 1.89% above expectations.
How did the market react to Axogen, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 0.53%, changed from $41.15 before the earnings release to $41.37 the day after.
When is Axogen, Inc. Common Stock expected to report next?
The next earning report is scheduled for Oct 27, 2026.
What are the forecasts for Axogen, Inc. Common Stock's next earnings report?
Based on 10
analysts, Axogen, Inc. Common Stock is expected to report EPS of $0.12 and revenue of $74.66M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement